← Eichor
Study identifier: NCT06428721 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

The Preventive Role of Fractionated Laser Resurfacing Against Actinic Neoplasia in an At-Risk Geriatric Population

Condition: Actinic Keratoses · Aging · Non-Melanoma Skin Cancer  ·  Sponsor: Wright State University

PhaseNA
Planned participants80
Who can joinAll sexes, 60 Years to no upper limit
Healthy volunteersNo

About this study

The purpose of this study is to determine if the Fractionated Laser Resurfacing (FLR) procedure can protect one forearm/wrist from precancerous actinic keratosis (AKs) as well as prevent skin cancer in older subjects with active AKs. This study builds on a similar study ongoing at the Dayton Veterans Administration dermatology clinic. This study is also testing if a photograph of the skin can be used to predict where the AKs and an skin cancers will form.

This description comes directly from the study's public registry record.

Talk to the study team

Manager, Clinical Research Operations  ·  937-245-7500  ·  pturesearch@wrightstatephysicians.org

Regulatory Specialist  ·  937-245-7500  ·  pturesearch@wrightstatephysicians.org

Always discuss trial participation with your own doctor first.

Locations (1)

Wright State PhysiciansFairborn, Ohio, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06428721